Precision BioSciences (DTIL) had its "buy" rating reaffirmed by JonesTrading. They now have a $30.00 price target on the stock.
Precision BioSciences, Inc. (DTIL) Presents at 25th Annual Needham Virtual Healthcare Conference Transcript [Seeking Alpha]
Precision BioSciences Expands ELIMINATE-B Trial Following Clinical Trial Application Approval in Two European Countries
Precision BioSciences to Participate in the 25th Annual Needham Virtual Healthcare Conference [Yahoo! Finance]
Precision BioSciences to Participate in the 25th Annual Needham Virtual Healthcare Conference